Fidan Ibrahim, Labreuche Julien, Huck Olivier, Agossa Kevimy
Oral Health Prev Dent. 2024 Dec 5;22:655-664. doi: 10.3290/j.ohpd.b5871494.
To compare the clinical performance of the combination of enamel matrix derivatives and bone substitutes (EMD+BG) with bone substitutes (BG) alone in the surgical treatment of periodontal intrabony and furcation defects.
Electronic databases (Medline, Embase and Web of Science) were searched for randomised controlled trials in humans that investigated the combination of EMD+BG vs BG alone in either intrabony or furcation defects with a minimal follow-up of 6 months. A random-effect meta-analysis was conducted according to the type of defect (intrabony or furcation defects) and the follow-up time (6 or ≥ 12 months).
From a total of 1583 entries, 9 randomised controlled clinical trials (RCTs) were retrieved and included in the qualitative and quantitative synthesis. All of them were included in the meta-analysis. The meta-analysis detected an additional clinical attachment level (CAL) gain in intrabony defects treated with EMD+BG compared to BG alone in studies with ≥ 12-month follow-up (mean difference = 0.67 mm, 95% CI [0.44 ; 0.90], p 0.00001). No additional benefit was found in furcation defects in terms of CAL gain or probing depth (PD) reduction.
The addition of EMD may improve the clinical outcomes of intrabony defects treated with bone substitutes. These findings may support the use of this combined therapy, particularly in large and non-contained defects.
比较釉基质衍生物与骨替代物联合应用(EMD+BG)和单纯使用骨替代物(BG)在牙周骨内和根分叉缺损手术治疗中的临床效果。
检索电子数据库(Medline、Embase和Web of Science),查找关于人类的随机对照试验,这些试验研究了EMD+BG与单纯BG在骨内或根分叉缺损中的联合应用,且随访时间至少为6个月。根据缺损类型(骨内或根分叉缺损)和随访时间(6个月或≥12个月)进行随机效应荟萃分析。
在总共1583条记录中,检索到9项随机对照临床试验(RCT)并纳入定性和定量分析。所有试验均纳入荟萃分析。荟萃分析发现,在随访时间≥12个月的研究中,与单纯BG相比,EMD+BG治疗骨内缺损时临床附着水平(CAL)有额外增加(平均差值=0.67mm,95%置信区间[0.44;0.90],p<0.00001)。在根分叉缺损方面,未发现CAL增加或探诊深度(PD)减少有额外益处。
添加EMD可能改善骨替代物治疗骨内缺损的临床效果。这些发现可能支持这种联合治疗的应用,特别是在大型和非局限性缺损中。